Valeant Pharmaceuticals Company Profile

Aggregated data from the web about Valeant Pharmaceuticals

Company Name	Valeant Pharmaceuticals
Website	https://www.bvvaleant.com
Snippet	Valeant Pharmaceuticals International is a classic case of how Wall Street clings to the power of an idea, and just how hard it can be to let go. Consultants and hedge funds used the drug company as a vessel to redesign a huge segment of the American economy, ostensibly to make it more efficient, while extracting profit in the process.
Type	Public
Founded	1959
Founder	Milan Panić
Revenue	US$8.601 billion (2019)[1]
Website	www.bauschhealth.com
Industry	Pharmaceuticals
Traded as	TSX: BHCNYSE: BHCS&P/TSX 60 component
Key people	Joseph C. Papa(Chairman & CEO)Paul S. Herendeen(Executive VP & CFO)Sam Eldessouky(Senior VP & Controller)
Net income	US$−1.788 billion (2019)[1]
Headquarters	Laval, Quebec, Intn'lBridgewater, NJ US HQ
Subsidiaries	Bausch & LombSalix PharmaceuticalsMedicis PharmaceuticalSolta MedicalOraPharma
Total assets	US$33.863 billion (2019)[1]
Total equity	US$1.063 billion (2019)[1]
Operating income	US$−0.203 billion (2019)[1]
Number of employees	~21,100 (December 2018)[1]

Valeant Pharmaceuticals is part of the Canada company list

Valeant Pharmaceuticals is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.